2-aminotropone: structure in first source
ID Source | ID |
---|---|
PubMed CID | 22634 |
CHEMBL ID | 3251332 |
SCHEMBL ID | 728071 |
MeSH ID | M0526492 |
Synonym |
---|
33504-43-7 |
2,4,6-cycloheptatrien-1-one, 2-amino- |
1-amino-2,4,6-cyclohepta-trien-1-one |
2-aminotropone |
brn 2204836 |
2-amino-2,4,6-cycloheptatrien-1-one |
2-aminocyclohepta-2,4,6-trien-1-one |
AKOS006340625 |
4-14-00-00035 (beilstein handbook reference) |
6264-93-3 |
CHEMBL3251332 |
SCHEMBL728071 |
2-amino-2,4,6-cycloheptatriene-1-one |
mfcd01734302 |
AS-62344 |
2-aminocyclohepta-2,4,6-trienone |
F11661 |
CS-0060480 |
DTXSID10955133 |
EN300-1425960 |
Z1203578079 |
Excerpt | Reference | Relevance |
---|---|---|
" The experiments suggesting a relationship between the activity and the bioavailability of the ester 19 are also described." | ( Troponoids. 3. Synthesis and antiallergy activity of N-troponyloxamic acid esters. Bagli, JF; Bogri, T; Lippmann, W; Martel, R; Palameta, B; Pugsley, T; Robinson, W, 1979) | 0.26 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1136020 | Drug metabolism in serum of Sprague-Dawley CD rat passive anaphylaxis model at 0.23 mmol/kg, iv | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10 | Troponoids. 3. Synthesis and antiallergy activity of N-troponyloxamic acid esters. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |